The Pharmacy Board of Australia
has drawn pharmacists’ attention
to the serious consequences which
apply to an individual or corporate
entity who “directs or incites a
pharmacist to do anything in the
course of practising pharmacy that
amounts to unprofessional conduct
or professional misconduct”.
The Board says it’s responding
to notifications from time to
time where pharmacists have
been issued directives by non-pharmacists
which impinge on their
ability to meet legal and ethical
obligations, with managerial staff
assuming authority for areas where
pharmacists are in fact responsible.
Practice issues cited include the
location of scheduled medicines
for sale in community pharmacies;
whether to supply generic brands
of S4 medicines; and how regulated
health services and therapeutic
goods are advertised.The above article was sent to subscribers in Pharmacy Daily's issue from 09 Dec 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Dec 13
THE stark health inequalities between Australians living in regional and metro areas have been highlighted in a new report from The Royal Flying Doctor Service (RFDS).
AN “AI explosion” is sweeping Australia’s healthcare sector, signalling the arrival of an “extraordinary era of medicine”, according to a new report from CSIRO.
THE Australian and New Zealand College of Advanced Pharmacy (ANZCAP) has celebrated the 1,000th pharmacist to complete its pharmacy recognition program (PD 24 Nov 2023).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.